Singer Nicholas Jason

DirectorEterna Therapeutics Inc. (ERNA) · full profile →Form 4 · filed Dec 6, 2022
Net Buying
Open-Market Buys
$929K
Open-Market Sells
$0
Net Open-Market Flow
$929K
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 2, 2022Buy(P)212K$3.28$697K266K
Dec 2, 2022Buy(P)71K$3.28$232K122K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 2, 2022Buy(P)425K$0.13$55K425K
Dec 2, 2022Buy(P)142K$0.13$18K142K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001140361-22-044631) within minutes of acceptance. Every field above traces to the original document. Verify it directly: